Founded in June 2002, Vesalius Ventures is dedicated to “accelerating the future of medicine” by becoming the premier conduit for enabling technologies that transform healthcare. Vesalius Ventures is in a unique position to access emerging technologies at their source and to bring exciting new opportunities to market from around the world. Vesalius Ventures’ strategy is to utilize the expertise and experience gained over the years in medical information and technology (Telemedicine) to create a unique investment firm, concentrating on early to mid-stage companies that need both equity capital and management assistance to achieve success.
Advances in medical technology, telecommunications and information technologies will be utilized for the delivery of healthcare. Creating novel business opportunities, identifying novel technologies, and exploiting attractive markets opportunities with tremendous potential growth are the goals of Vesalius Ventures.
Vesalius Ventures was created through an investment of three venture and corporate partners of Vanguard Ventures, Fremont Ventures and Guidant Corporation. This group was joined a year later by Sevin Rosen Funds. During the following years of operations of the accelerator, the firm also attracted the attention of other companies looking to develop new opportunities in Telemedicine through a client relationship. In 2008, Opal Ventures and Vesalius established a partnership to bring medical technologies from Israel and Europe to the US market. This created a unique opportunity for Vesalius to expand the investments in its portfolio.